# Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer

> **NCT01493310** · PHASE1 · COMPLETED · sponsor: **University of Chicago** · enrollment: 9 (actual)

## Conditions studied

- Male Breast Cancer
- Recurrent Breast Cancer
- Stage IIIA Breast Cancer
- Stage IIIB Breast Cancer
- Stage IIIC Breast Cancer
- Stage IV Breast Cancer

## Interventions

- **DRUG:** mifepristone
- **DRUG:** placebo
- **DRUG:** nab-paclitaxel

## Key facts

- **NCT ID:** NCT01493310
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2018-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01493310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01493310, "Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01493310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*